Prognosis and Patient-Reported Outcomes of Combined Local Treatments (Radiotherapy and Surgery or Radiotherapy Alone) with Almonertinib and Chemotherapy in EGFR-Mutant Stage III-N3 Non-Small Cell Lung Cancer: A Prospective, Single-Center, Phase II Trial
/ Not yet recruitingN/AIIT A Prospective, Multicenter, Randomized Controlled Study of Three-dimensional Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors
The goal of this clinical trial is to learn the evidence-based medical value of 3D visualization techniques to improve tumor control, preservation of renal function, and perioperative safety in robot-assisted nephron sparing surgery for complex renal tumors. The main question it aims to answer is:
Is 3D visualization techniques more effective in improving robot-assisted nephron sparing surgery for complex renal tumors in terms of tumor control, renal function preservation, and perioperative safety.
The researchers will randomize participants into a 3D trial group and a conventional group for comparison.
Participants will:
Complete Blood routine, liver and kidney function tests on the first and third day after operation.
Have Renography at 3 and 12 months after the operation. Cooperate with follow-up visits.
Prospective, single-center, Phase II clinical study of the safety and efficacy of Tirellizumab combined with chemotherapy in the conversion treatment of locally advanced unresectable esophageal squamous cell carcinoma
100 项与 辽宁省肿瘤医院(辽宁省肿瘤研究所) 相关的临床结果
0 项与 辽宁省肿瘤医院(辽宁省肿瘤研究所) 相关的专利(医药)
100 项与 辽宁省肿瘤医院(辽宁省肿瘤研究所) 相关的药物交易
100 项与 辽宁省肿瘤医院(辽宁省肿瘤研究所) 相关的转化医学